SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-23-014638
Filing Date
2023-04-28
Accepted
2023-04-28 14:05:33
Documents
27

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 2919730
2 forms-1_001.jpg GRAPHIC 5044
3 forms-1_002.jpg GRAPHIC 34890
4 image_001.jpg GRAPHIC 20725
5 image_002.jpg GRAPHIC 34166
6 forms-1_004.jpg GRAPHIC 12965
7 forms-1_005.jpg GRAPHIC 13983
8 forms-1_006.jpg GRAPHIC 25725
9 forms-1_007.jpg GRAPHIC 15984
10 forms-1_008.jpg GRAPHIC 28301
11 forms-1_010.jpg GRAPHIC 14230
12 forms-1_011.jpg GRAPHIC 28947
13 forms-1_012.jpg GRAPHIC 30130
14 forms-1_013.jpg GRAPHIC 22261
15 forms-1_014.jpg GRAPHIC 22521
16 forms-1_015.jpg GRAPHIC 17612
17 forms-1_016.jpg GRAPHIC 20759
18 forms-1_017.jpg GRAPHIC 14212
19 forms-1_018.jpg GRAPHIC 14386
20 forms-1_019.jpg GRAPHIC 16449
21 forms-1_020.jpg GRAPHIC 15674
22 forms-1_021.jpg GRAPHIC 16302
23 forms-1_022.jpg GRAPHIC 16184
24 forms-1_023.jpg GRAPHIC 23762
25 forms-1_024.jpg GRAPHIC 52025
26 forms-1_025.jpg GRAPHIC 23650
27 forms-1_026.jpg GRAPHIC 4795
  Complete submission text file 0001493152-23-014638.txt   3675408
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-269442 | Film No.: 23863828
SIC: 2834 Pharmaceutical Preparations